Comparison of postoperative awakening between ciprofol and propofol in elderly patients undergoing hip replacement surgery: a single-blind, randomized, controlled trial

被引:0
作者
Yang, Dawei [1 ]
Zhou, Jie [2 ]
Sun, Luyu [1 ]
Li, Min [1 ]
Zhang, Jianyou [1 ]
机构
[1] Yangzhou Univ, Affiliated Hosp Yangzhou Univ, Dept Anesthesiol, Yangzhou, Jiangsu, Peoples R China
[2] Yangzhou Univ, Affiliated Hosp Yangzhou Univ, Dept Obstet & Gynecol, Yangzhou, Jiangsu, Peoples R China
关键词
Aged; Arthroplasty; replacement; hip; Postoperative period; GENERAL-ANESTHESIA; INDUCTION; MAINTENANCE; MULTICENTER; EFFICACY; PHASE-3; SAFETY;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: The aim of this paper was to compare the impact of continuous infusion of ciprofol versus propofol on postoperative awakening in elderly patients following hip replacement surgery. METHODS: Patients were randomized into two groups (N.45 each): the ciprofol group and the propofol group. The ciprofol group received ciprofol for anesthesia induction and maintenance, while the propofol group underwent anesthesia induction and maintenance using propofol. The primary outcome was awakening time. Secondary outcomes included spontaneous breathing recovery time, extubation time, time to modified Aldrete Score >9, modified observer's assessment of alertness/sedation (MOAA/S) scores, anesthetic dosage, volume of fluid replacement, urine output and administration of vasoactive drugs. RESULTS: The Ciprofol group exhibited a significantly prolonged awakening time (11.0 +/- 6.4 min vs. 7.4 +/- 4.3 min, P=0.003), spontaneous breathing recovery time (9.9 +/- 6.3 min vs. 5.9 +/- 4.3 min, P=0.001), and extubation time (12.0 [8.016.0] min vs. 8.5 [6.0-11.0] min, P=0.005), and reduced requirement for intraoperative fluid replacement (728.9 +/- 254.2 mL vs. 908.3 +/- 287.5 mL, P=0.003), increased urine output (235.1 +/- 102.1 mL vs. 173.5 +/- 106.2 mL, P=0.007), decreased likelihood of vasoactive drug administration (15/30 vs. 28/14, P=0.002). No significant differences were observed between the two groups in terms of reaching a modified Aldrete Score >9, MOAA/S scores at 0, 5, 15, or 30 minutes post-extubation, or occurrence of adverse reactions (P>0.05). The dosage of remifentanil was significantly higher in the ciprofol group [5.4 (2.7-7.4) mu gkg(-1)h(-1) vs. 3.4 (1.9-4.3) mu gkg(-1)h(-1), P0.004], with a mean maintenance dose of ciprofol at 0.8 mgkg(-1)h(-1) (range: 0.5 to 1.2 mgkg(-1)h(-1)). CONCLUSIONS: Compared to propofol, the administration of ciprofol in elderly patients following hip replacement surgery is associated with prolonged awakening time, spontaneous breathing recovery time, and extubation. The average intravenous maintenance dosage of ciprofol in geriatric patients under general anesthesia was 0.8 mgkg(-1)h(-1).
引用
收藏
页码:1074 / 1081
页数:8
相关论文
共 20 条
[1]   The efficacy and safety of ciprofol use for the induction of general anesthesia in patients undergoing gynecological surgery: a prospective randomized controlled study [J].
Chen, Ben-zhen ;
Yin, Xin-yu ;
Jiang, Li-hua ;
Liu, Jin-hui ;
Shi, Yan-yan ;
Yuan, Bi-ying .
BMC ANESTHESIOLOGY, 2022, 22 (01)
[2]   Efficacy and safety of ciprofol for general anaesthesia induction in elderly patients undergoing major noncardiac surgery A randomised controlled pilot trial [J].
Ding, Yun-ying ;
Long, Yu-qin ;
Yang, Hao-tian ;
Zhuang, Kai ;
Ji, Fu-hai ;
Peng, Ke .
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2022, 39 (12) :960-963
[3]   Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial [J].
Doi, Matsuyuki ;
Morita, Kiyoshi ;
Takeda, Junzo ;
Sakamoto, Atsuhiro ;
Yamakage, Michiaki ;
Suzuki, Toshiyasu .
JOURNAL OF ANESTHESIA, 2020, 34 (04) :543-553
[4]  
Gan TJ, 2024, Compare son of the Etheary of HSK3486 and Propatol for Indsetion of General Anesthesia in Adults: A Multicenter, Randomized, Double-blud, Controlled, Phase 3 Nomakenonty Tnal Anes thestology, V140, P600
[5]   Hydrothermal Synthesis of Nanomaterials [J].
Gan, Yong X. ;
Jayatissa, Ahalapitiya H. ;
Yu, Zhen ;
Chen, Xi ;
Li, Mingheng .
JOURNAL OF NANOMATERIALS, 2020, 2020
[6]   A systematic review and meta-analysis comparing the efficacy and safety of ciprofol (HSK3486) versus propofol for anesthetic induction and non-ICU sedation [J].
Hung, Kuo-Chuan ;
Chen, Jen-Yin ;
Wu, Shao-Chun ;
Huang, Po-Yu ;
Wu, Jheng-Yan ;
Liu, Ting-Hui ;
Liu, Chien-Cheng ;
Chen, I-Wen ;
Sun, Cheuk-Kwan .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[7]   Safety, Pharmacokinetics, and Pharmacodynamics of a Single Bolus of the γ-aminobutyric Acid (GABA) Receptor Potentiator HSK3486 in Healthy Chinese Elderly and Non-elderly [J].
Li, Xiaojiao ;
Yang, Deming ;
Li, Qianqian ;
Wang, Hong ;
Wang, Meng ;
Yan, Pangke ;
Wu, Nan ;
Li, Fangqiong ;
Ma, Shiping ;
Ding, Yanhua ;
Liu, Jingrui ;
Wang, Hushan .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[8]   Efficacy and safety of ciprofol vs. propofol for the induction and maintenance of general anaesthesia A multicentre, single-blind, randomised, parallel-group, phase 3 clinical trial [J].
Liang, Peng ;
Dai, Meng ;
Wang, Xiao ;
Wang, Dongxin ;
Yang, Mengchang ;
Lin, Xuemei ;
Zou, Xiaohua ;
Jiang, Ke ;
Li, Yalan ;
Wang, Liangrong ;
Shangguan, Wangning ;
Ren, Jinghua ;
He, Hefan .
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2023, 40 (06) :399-406
[9]  
Liv L., 2024, J Clin Apeath, V92
[10]   Efficacy and Safety of HSK3486 for Anesthesia/Sedation in Patients Undergoing Fiberoptic Bronchoscopy: A Multicenter, Double-Blind, Propofol-Controlled, Randomized, Phase 3 Study [J].
Luo, Zhen ;
Tu, Hong ;
Zhang, Xiang ;
Wang, Xiao ;
Ouyang, Wen ;
Wei, Xinchuan ;
Zou, Xiaohua ;
Zhu, Zhaoqiong ;
Li, Yalan ;
Shangguan, Wangning ;
Wu, Hui ;
Wang, Yaping ;
Guo, Qulian .
CNS DRUGS, 2022, 36 (03) :301-313